Trials / Completed
CompletedNCT01281657
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to collect long-term data on safety and effectiveness of fingolimod, particularly including clinical disease and patient outcome related parameters such as relapse and disability, in patients who have participated in prior trials within the fingolimod clinical development program. Furthermore, this study explores the incidence of selected safety related outcomes of fingolimod treatment during follow-up visits within the context of routine medical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fingolimod |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-01-24
- Last updated
- 2012-09-06
Locations
58 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01281657. Inclusion in this directory is not an endorsement.